BDBM373523 US10421747, Compound 6::US9902714, Compound 6

SMILES CCn1cc(cn1)-c1cnc2ccc(cc2n1)N1CCN(C)Cc2c(OC)cc(OC)cc12

InChI Key InChIKey=JOFZGVSUUQEGAJ-UHFFFAOYSA-N

Data  10 Kd

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 10 hits for monomerid = 373523   

TargetFibroblast growth factor receptor 1(Human)
Astex Therapeutics

US Patent
LigandPNGBDBM373523(US9902714, Compound 6 | US10421747, Compound 6)
Affinity DataKd:  2.40E+3nMAssay Description:FGFR1: In a final reaction volume of 30 μL, FGFR1 (h) (25 ng/ml) was incubated with 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.1 mM Na3VO4, 0.0...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/21/2020
Entry Details
Go to US Patent

TargetFibroblast growth factor receptor 2(Human)
Astex Therapeutics

US Patent
LigandPNGBDBM373523(US9902714, Compound 6 | US10421747, Compound 6)
Affinity DataKd:  2.90E+3nMAssay Description:FGFR2: In a final reaction volume of 30 μL, FGFR2 (h) (150 ng/ml) was incubated with 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.1 mM Na3VO4, 0....More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/21/2020
Entry Details
Go to US Patent

TargetFibroblast growth factor receptor 3(Human)
Astex Therapeutics

US Patent
LigandPNGBDBM373523(US9902714, Compound 6 | US10421747, Compound 6)
Affinity DataKd:  2.20E+3nMAssay Description:FGFR3: In a final reaction volume of 30 μL, FGFR3 (h) (40 ng/ml) was incubated with 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.1 mM Na3VO4, 0.0...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/21/2020
Entry Details
Go to US Patent

TargetFibroblast growth factor receptor 4(Human)
Astex Therapeutics

US Patent
LigandPNGBDBM373523(US9902714, Compound 6 | US10421747, Compound 6)
Affinity DataKd: >3.00E+3nMAssay Description:FGFR4: In a final reaction volume of 30 μL, FGFR4 (h) (60 ng/ml) was incubated with 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.1 mM Na3VO4, 0.0...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/21/2020
Entry Details
Go to US Patent

TargetVascular endothelial growth factor receptor 2(Human)
Astex Therapeutics

US Patent
LigandPNGBDBM373523(US9902714, Compound 6 | US10421747, Compound 6)
Affinity DataKd: >3.00E+3nMAssay Description:KDR (VEGFR2): In a final reaction volume of 30 μL, KDR (h) (150 ng/ml) was incubated with 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.1 mM Na3VO...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/21/2020
Entry Details
Go to US Patent

TargetFibroblast growth factor receptor 1(Human)
Astex Therapeutics

US Patent
LigandPNGBDBM373523(US9902714, Compound 6 | US10421747, Compound 6)
Affinity DataKd:  2.40E+3nMAssay Description:Kinase enzyme binding affinities of compounds disclosed herein were determined using the KINOMEscan technologyMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2020
Entry Details
Go to US Patent

TargetFibroblast growth factor receptor 2(Human)
Astex Therapeutics

US Patent
LigandPNGBDBM373523(US9902714, Compound 6 | US10421747, Compound 6)
Affinity DataKd:  2.90E+3nMAssay Description:Kinase enzyme binding affinities of compounds disclosed herein were determined using the KINOMEscan technologyMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2020
Entry Details
Go to US Patent

TargetFibroblast growth factor receptor 3(Human)
Astex Therapeutics

US Patent
LigandPNGBDBM373523(US9902714, Compound 6 | US10421747, Compound 6)
Affinity DataKd:  2.20E+3nMAssay Description:Kinase enzyme binding affinities of compounds disclosed herein were determined using the KINOMEscan technologyMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2020
Entry Details
Go to US Patent

TargetFibroblast growth factor receptor 4(Human)
Astex Therapeutics

US Patent
LigandPNGBDBM373523(US9902714, Compound 6 | US10421747, Compound 6)
Affinity DataKd: >3.00E+3nMAssay Description:Kinase enzyme binding affinities of compounds disclosed herein were determined using the KINOMEscan technologyMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2020
Entry Details
Go to US Patent

TargetVascular endothelial growth factor receptor 2(Human)
Astex Therapeutics

US Patent
LigandPNGBDBM373523(US9902714, Compound 6 | US10421747, Compound 6)
Affinity DataKd: >3.00E+3nMAssay Description:Kinase enzyme binding affinities of compounds disclosed herein were determined using the KINOMEscan technologyMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2020
Entry Details
Go to US Patent